UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: biosimilars

Poster Presentations Release: Biologics and Biosimilars

Presented at the 4th Biologics & Biosimilars Congress, these poster presentations are now available to download and share with your colleagues.

Read More

Round-Up of Top Biologics News

With new discoveries and developments in Asthma, Diabetes and Cancer, there has been some interesting news to catch up on this month. Take a look at the list below to find out more:

Read More

Continuous or intensified bioprocessing? The gold standard for improved productivity

Process intensification and continuous biomanufacturing continue to attract a lot of interest within the biopharmaceutical industry as a method that can increase productivity and make the most efficient use of production assets.

Read More

Presentation Slide Release: Biologics Discovery and Development

Presented at the 3rd Biologics and Biosimilars Congress, these 3 sets of slides are available to download and share with your colleagues.

Read More

Developing and Manufacturing Innovative Biologics: Obstacles and Opportunities

In this 30 minute presentation, Ralf Schumacher discusses developing and manufacturing biologics. Translating discovery knowledge into process design, technology upgrading and gated development paradigms are explored.

Read More

Assays in clinical trials and pharmacovigilance

Assays are crucial during pre-clinical and clinical trials, and for pharmacovigilance. By this stage, the molecule has already been fully profiled with a mechanism of action, and efficacy and safety are now being assessed in vivo.

Read More

The pivotal role of assays in biologic and biosimilar discovery and development

The quality, accuracy and reliability of assays is particularly critical when developing biologics and biosimilars. Assays for biologics are more complicated than for small molecules, often relying on assays which provide relative measures in contrast to the more absolute measurements gained from standard crystallisation or purity profiles.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive